Clinical Trials

53 enrolled 11 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT04521348 2025-07-24

Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer

103 enrolled

Thyroid Neoplasms

NCT03246958 2025-06-19

Nivolumab Plus Ipilimumab in Thyroid Cancer

53 enrolled 19 charts

Thyroid Neoplasms

NCT04552769 2025-06-05

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

9 enrolled 10 charts

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT00381641 2025-03-28

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

63 enrolled 12 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT05175404 2025-03-04

Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

8 enrolled

Thyroid Neoplasms

NCT02152137 2025-01-27

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

19 enrolled 13 charts

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT02393690 2024-07-26

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

60 enrolled 12 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT02383927 2024-07-11

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

63 enrolled 19 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Thyroid Neoplasms

NCT04782856 2024-06-14

Energy Metabolism in Thyroidectomized Patients

13 enrolled 10 charts

Goiter, Hypothyroidism, Thyroid Neoplasms

NCT00537095 2024-04-19

Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer

164 enrolled 10 charts

Thyroid Neoplasms

NCT03012620 2024-02-28

AcSé

CNSEndocrineGynecologicHead & NeckLymphoidSarcoma

334 enrolled

Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Carcinoma, Neuroendocrine, Lymphoma, Extranodal NK-T-Cell

NCT02947035 2023-07-14

Molecular Testing to Direct Extent of Initial Thyroid Surgery

100 enrolled

Thyroid Neoplasms, Thyroid Nodule

NCT01882816 2022-12-29

Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

27 enrolled 12 charts

Thyroid Neoplasms

NCT02731352 2022-01-20

Study of Apatinib in Patients With Differentiated Thyroid Cancer

20 enrolled

Thyroid Neoplasms

NCT02702388 2021-11-24

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

241 enrolled 32 charts

Thyroid Neoplasms

NCT00936858 2021-10-22

RAD001 for Patients With Radioiodine Refractory Thyroid Cancer

50 enrolled 14 charts

Thyroid Neoplasms

NCT00124527 2021-06-16

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

35 enrolled

Thyroid Neoplasms

NCT01270321 2021-02-17

Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

42 enrolled 11 charts

Thyroid Neoplasms

NCT01728623 2020-08-14

A Study of E7080 in Subjects With Advanced Thyroid Cancer

51 enrolled 15 charts

Thyroid Neoplasms

NCT00668811 2020-08-05

IIT Sutent

23 enrolled 7 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT01788982 2020-07-31

Nintedanib(BIBF1120) in Thyroid Cancer

100 enrolled

Thyroid Neoplasms, Carcinoma, Medullary

NCT00287287 2020-06-12

REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas

25 enrolled 9 charts

Thyroid Neoplasms

NCT00784303 2020-04-22

Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology

117 enrolled 19 charts

Thyroid Neoplasms

NCT00625846 2020-02-26

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

152 enrolled 16 charts

Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT02614495 2020-02-13

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

66 enrolled

Thyroid Neoplasms

NCT01013597 2019-11-29

Trial of LBH589 in Metastatic Thyroid Cancer

13 enrolled 11 charts

Thyroid Diseases, Thyroid Neoplasms

NCT00654238 2019-11-18

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

59 enrolled 8 charts

Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT02084732 2019-11-13

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

35 enrolled

Thyroid Neoplasms

NCT01813136 2019-08-16

Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma

168 enrolled

Thyroid Neoplasms

NCT02390934 2019-06-11

RAD-THYR

13 enrolled

Thyroid Neoplasms

NCT00104871 2018-12-19

Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

24 enrolled 6 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00085293 2018-11-29

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

12 enrolled 4 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00181168 2018-11-02

Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

63 enrolled 6 charts

Thyroid Neoplasms

NCT00896454 2018-10-17

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cellThoracic

33 enrolled 22 charts

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Hypercalcemia, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Parathyroid Neoplasms, Thyroid Neoplasms

NCT01025453 2018-08-15

Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer

37 enrolled 11 charts

Thyroid Diseases, Thyroid Neoplasms

NCT01502410 2018-06-26

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

EndocrineGenitourinaryHead & Neck

20 enrolled 14 charts

Thyroid Cancer, Papillary, Wilms Tumor, Thyroid Neoplasms

NCT01182285 2018-05-16

A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin

13 enrolled 11 charts

Thyroid Neoplasms

NCT00098345 2018-05-07

Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer

40 enrolled 12 charts

Thyroid Neoplasms

NCT01811212 2018-04-03

Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer

25 enrolled 11 charts

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT02114658 2017-08-03

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

18 enrolled

Thyroid Neoplasms, Carcinoma, Medullary

NCT00026533 2017-06-06

Thalidomide in Treating Patients With Thyroid Cancer

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT00095836 2017-05-31

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

27 enrolled 16 charts

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT00519896 2017-04-25

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

35 enrolled 8 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT01831726 2017-03-20

SIGNATURE

DermatologicGastrointestinalGynecologicHead & NeckOther hematologic neoplasmSarcomaThoracic

80 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Gastrointestinal Stromal Tumors

NCT00729157 2017-03-15

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

41 enrolled 10 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00118248 2017-02-15

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

41 enrolled 10 charts

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary

NCT00358956 2017-01-30

A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

19 enrolled 10 charts

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

NCT00559949 2017-01-30

Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine

39 enrolled 8 charts